Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

NCT00560417 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Lispro Protamine Suspension
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company